HIGHLIGHTS
- who: Xiaofei Zhang and collaborators from the State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Department of Oncology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China have published the article: KRAS mutant pancreatic cancer, in the Journal: (JOURNAL)
- what: Immunoblot analysis was carried out to investigate changes in p62 and autophagy. The authors aimed to explore the impact of trametinib and/or JQ1 on KRAS mutant pancreatic cancer and address the potential mechanism. The studies demonstrated that the synergistic effect of trametinib and JQ1 combined therapy might induce different . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.